<DOC>
	<DOC>NCT02894242</DOC>
	<brief_summary>This investigation is designed to evaluate the performance as well as the patients overall acceptance of the mask.</brief_summary>
	<brief_title>The Evaluation of a Nasal Pillows Mask for the Treatment of Obstructive Sleep Apnea (OSA)</brief_title>
	<detailed_description>A minimum of 20 OSA participants who currently use a nasal pillows mask will be recruited for the trial. Participant will be on the trial for three weeks - first week will be a collection of Positive Airway Pressure (PAP) baseline data on the participant's usual mask. The participant will then use the trial mask in-home for 2 weeks. There is also an option of a two month extension if the participant wish to continue on the trial mask.</detailed_description>
	<mesh_term>Apnea</mesh_term>
	<mesh_term>Sleep Apnea Syndromes</mesh_term>
	<mesh_term>Sleep Apnea, Obstructive</mesh_term>
	<criteria>Adult (18+ years of age) Able to give consent Apnea hypopnea Index (AHI)â‰¥ 5 on diagnostic night Prescribed PAP for OSA Existing nasal pillows user Inability to give consent Patients who are in a coma or a decreased level of consciousness Anatomical or physiological conditions making automatic positive airway pressure (APAP) therapy inappropriate (e.g. unconsolidated facial structure) Commercial drivers who are investigated by New Zealand Transport Agency Current diagnosis of carbon dioxide (CO2) retention Pregnant or may think they are pregnant</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
</DOC>